01
Cash & equivalents increased 55.1%
Cash & equivalents changed +55.1% from the comparable as-filed period.
$22.9M→$35.5MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTCompass Therapeutics, Inc.'s latest supported as-filed period reports net income of -$25.2M, 26.5% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +55.1% from the comparable as-filed period.
Net income changed -26.5% from the comparable as-filed period.
Operating income changed -28.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CMPX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001171843-26-005295SEC ↗8-KAug 6, 2026Period Aug 6, 20260001171843-26-005292SEC ↗8-KJul 1, 2026Period Jul 1, 20260001171843-26-004428SEC ↗8-KJun 23, 2026Period Jun 22, 20260001171843-26-004224SEC ↗8-KJun 11, 2026Period Jun 10, 20260001171843-26-004068SEC ↗10-QMay 5, 2026Period Mar 31, 20260001171843-26-003006SEC ↗8-KMay 5, 2026Period May 5, 20260001171843-26-003005SEC ↗4/ATransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Apr 29, 2026Filed Apr 30, 2026 | Lerner NeilChief Accounting Officer | Open Market PurchaseDirect · amended | 15,000 | $2 | $28,350 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed +72.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001171843-26-002894